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Abstract
An advanced intermediate in a projected synthesis of pactamycin has been prepared. Early
installation of the C1-dimethylurea functionality allows for its participation in a diastereoselective,
chelation-controlled addition of organometal nucleophiles to the C5 prochiral ketone. Four of the
molecule’s six stereocenters are set with a ketone functional handle provided for subsequent
manipulation.
First isolated in 1961 from a fermentation broth of Streptomyces pactum var pactum,
pactamycin (1) is a potent, universal inhibitor of translocation.1,2 Through use of its aniline
and salicylate moieties, pactamycin mimics a dinucleotide, interacting with stem loops in the
16S RNA, garnering its antitumor, antimicrobial, antiviral, and antiprotozoal activity.3 The
unique stereochemically and functionally dense structure was proposed in 19704 and revised
after X-ray analysis in 1972.5
Pactamycin’s cyclopentane core features stereogenic carbons at each position with an
additional sidechain stereocenter at C7. The molecule is heteroatom-rich and contains urea,
salicylate, and aniline functionality about the densely-substituted core. The synthetic
challenge posed by this complex target had only received limited attention in the literature
with two synthetic studies,6 until the first total synthesis was realized in 2011 by Hanessian
and coworkers.7 This Letter details progress on a pactamycin core synthesis, specifically
highlighting issues associated with the diastereoselective construction of the C5 tertiary
carbinol.
Our retrosynthesis is outlined in Scheme 1. We envisaged access to 1 through selective
manipulation of alcohol and amine functinonality at C4 and C3, respectively, from
stereochemically-complete core 2.
The C4 tertiary alcohol and C2/C3 diamine moiety could be installed through allylic and
alkene functionalization of cyclopentene 3, which would be constructed employing ring-
closing metathesis of diene 4. Prior to cyclopentene formation, we believed the C1, C5, and
C7 stereocenters could be completed with high diastereoselectivity in the acyclic form. We
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proposed formation of the C5 stereocenter via functionalized vinyl addition to methyl ketone
5. The first stereocenter, C1, would be completed employing an enantioselective allylation
followed by diastereoselective ketone reduction at C7 of a substrate derived from methyl
acetoacetate.
Rather than advancing the unusual C1 dimethyl urea in a protected form, we were intrigued
by possible directing or chelating effects that this Lewis base might exert during key bond
constructions. To this end, we elected to install this C1 functionality in its final desired form
early in the synthesis. Diazo transfer onto methyl acetoacetate with p-
acetamidobenzenesulfonyl azide (p-ABSA)8 proceeded in excellent yield to give α-diazo
methyl acetoacetate (7, Scheme 2). A Rh-catalyzed N–H insertion reaction adapted from the
method reported by Janda9 was then used for installation of the dimethylurea (8). This
pronucleophile was subjected to the allylation conditions developed by Ito10 to provide the
C1 stereocenter ((±)-9). An unoptimized asymmetric variant of this reaction using the Ito
conditions provided enantioenriched (R)-9 (er 92:8, Scheme 3). The allylation was followed
by a diastereoselective L-Selectride® reduction which provided the desired diastereomer in
72% yield.10 Silyl protection of the C7 alcohol with TBSOTf proceeded in excellent yield to
give methyl ester 10.
Conversion of the methyl ester 10 to a methyl ketone was unsuccessful under standard
conditions (MeMgBr, MeLi, Cp2TiMe2) due to a lack of reactivity attributed to congestion
at the adjacent C1 center; however, TMSCH2Li was shown to possess unique
nucleophilicity, smoothly providing ketone 11 after a methanol quench (Scheme 4).11 With
the desired C5 ketone in hand we tested a variety of nucleophilic additions to evaluate
reaction efficiency, diastereoselectively, and influence of the C1 urea during formation of
the C4–C5 bond.
Standard nucleophilic additions to 11 were unsuccessful. Recovered starting material
suggested an extreme degree of steric hindrance and/or competitive enolization of the
methyl ketone. To overcome this impasse, cerium trichloride was deployed to both activate
the ketone and render the organometal nucleophiles less basic.12,13 Isopropenyl Grignard
was used as a model nucleophile and, when used with added CeCl3, provided tertiary
carbinol 12 in 59% and 2.7:1 diastereoselectivity. Ring-closing metathesis with Grubbs’s
second generation catalyst provided cyclopentene 13; nOesy analysis on this rigidified
structure revealed the undesired syn relationship between the C5 hydroxyl and C1 urea.14
The conversion of 11 to 12 demonstrated that organometal additions to a hindered α-ureido
ketone were feasible and potentially diastereoselective, dictated by the C1/C7 stereodiad.
Since the C5 alcohol arises from two consecutive organometal additions to a carbonyl
electrophile, it occurred to us that reversing the order of nucleophile additions
(functionalized vinyl, then methyl) might deliver the desired stereochemical outcome. To
this end, we set out to synthesize a functionalized C5 enone electrophile.
A reduction/oxidation sequence of methyl ester 10 with DIBAL-H and Dess-Martin
periodinane proved most reliable in providing aldehyde 14 (Scheme 5). The aldehyde
functionality at C5 permitted addition of lithiated 2-bromopropenol15 (15) in good yield to
give diol 16.16 A selective triethylsilylation of the primary alcohol followed by Dess-Martin
oxidation yielded α,β-enone 17.
Methyl Grignard addition in the presence of CeCl3 proceeded in excellent yield providing
the 1,2-addition product as a single diastereomer (18). Ring-closing metathesis gave
cyclopentene 19; nOesy analysis showed the desired stereochemistry at C5, confirming our
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hypothesis. Notably, this second-generation route allowed for the facile introduction of
critical hydroxymethylene functionality at C4.
The stereochemical outcome of C5 ketone nucleophilic additions may be analyzed in the
context of the following transition state proposal (20, Scheme 6). A five-membered chelate
involving the urea, ketone, and metal (M = CeX2, MgX) could lock the electrophile in a
conformation wherein the bulky, branched tert-butyldimethylsilyloxyethyl group shields
addition from the Si face providing a modest preference in the methyl ketone case, and
exclusive Re facial addition in the functionalized ketone system. This chelation effect has
been invoked sporadically in additions to fully substituted cyclic α-amino ketones (to an α-
oxo-azaspirocyle,17 and an α-amino cyclobutanone18). Two outcomes flow from this
analysis: (1) the identity of nucleophile has little effect on the stereochemical outcome, and
(2) the decision to incorporate the dimethylurea early is crucial in achieving the proper C5
stereochemistry via this synthetic route. The enhanced diastereocontrol with the more
sterically demanding enone 17 might be consistent with “nonvertical” approach trajectories
that accentuate the influence of chiral information in the electrophile.19
The C3–C4 alkene was expected to provide a useful handle for the elaboration of the
remaining functionality in the pactamycin core. Efforts to install an allylic amine or
otherwise oxidize the C2 methylene were unsuccessful, so our efforts turned to alkene
elaboration. OsO4-catalyzed dihydroxylation of cyclopentene 19 provided syn-diol 21 in
good yield as a single diastereomer (Scheme 7).20 Swern oxidation gave the α-hydroxy
ketone 22 in 88% yield and avoided competitive oxidative cleavage that was observed with
other oxidants (Dess–Martin periodinane, PCC). Diol 21, ketone 22, and their derivatives
are expected to be useful intermediates for the introduction of the C2 amine and the C3
aniline.
An alternate protecting group scheme was also realized upon treating ketone 22 with 2,2-
dimethoxypropane (2,2-DMP) and catalytic acid. Under these conditions, both silyl ethers
were cleaved, and the C4 1,3-dioxolane and C1/C7 1,3-dioxane were selectively
constructed, conveniently protecting the tetraol (23). Diacetonide 23 was highly crystalline
and used for X-ray analysis (Figure 1). The crystal structure confirmed our nOesy-based
stereochemical assignments and provided insight into the preferred conformation of
functional groups, aiding in the planning of further manipulations.21
In conclusion, we have in fifteen steps converted methyl acetoacetate to diacetonide 23, an
advanced intermediate in a projected synthesis of pactamycin. Four of the six stereocenters,
including the contiguous fully substituted C1/C5/C4 stereotriad, have been established with
high levels of stereocontrol. The stereochemical issues associated with the creation of the C5
tertiary alcohol were studied and a stereochemical model for organometal additions to
highly substituted α-NH-ketones was advanced. A C3 ketone arose from functionalization
of the cyclopentene core and provides a functional handle for subsequent manipulation.
Ongoing efforts are focused on α-amination of the C3 ketone and elaboration of the ketone
to the C3 aniline functionality.
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X-ray structure of diacetonide 23.
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Retrosynthetic Analysis of Pactamycin
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Diastereoselective Assembly of the C1 and C7 Stereocenters
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2-Propenide Addition to a C5 Methyl Ketone
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Methide Addition to a C5 Functionalized Enone
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Proposed Transition State for C5 Nucleophilic
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Elaboration of the C3–C4 Alkene
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